Skip to main content
SpringerLink
Log in
Book cover

Hepatology Principles and Practice pp 691–714Cite as

Chronic hepatitis

  • Chapter

  • 1520 Accesses

Keywords

  • Chronic Hepatitis
  • Chronic Active Hepatitis
  • Chronic Viral Hepatitis
  • Adefovir Dipivoxil
  • Hepatitis Delta Virus

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Chronic hepatitis

  1. Batts, K.P., Ludwig, J.: Chronic hepatitis — an update on terminology and reporting. Amer. J. Surg. Pathol. 1995; 19: 1409–1417

    CAS  Google Scholar 

  2. Bianchi, L.: Necroinflammatory liver diseases. Semin. Liver Dis. 1986; 6: 185–198

    CAS  PubMed  Google Scholar 

  3. Chevallier, M., Guerret, S., Chossegros, P., Gerard, F., Grimaud, J.-A.: A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20: 349–355

    CrossRef  CAS  PubMed  Google Scholar 

  4. Cho, S.G., Kim, M.Y., Kim, H.J., Choi, W., Shin, S.H., Hong, K.C., Kim, Y.B., Lee, J.H., Suh, C.H.: Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001; 221: 740–746

    CAS  PubMed  Google Scholar 

  5. Colloredo, G., Guido, M., Sonzogni, A., Leandro, G.: Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 2003; 39: 239–244

    CrossRef  PubMed  Google Scholar 

  6. Crawford, A.R., Lin, X.Z., Crawford, J.M.: The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998; 28: 323–331

    CAS  PubMed  Google Scholar 

  7. DeGroote, J., Desmet, V.J., Gedigk, P., Korb, G., Popper, H., Poulsen, H., Scheuer, P.J., Schmid, M., Thaler, H., Uehlinger, E., Wepler, W.: A classification of chronic hepatitis. Lancet 1968/II: 626–628

    Google Scholar 

  8. Desmet, F.J., Gerber, M., Hoofnagle, J.H., Manns, M., Scheuer, P.J.: Classification of chronic hepatitis. Diagnosis, grading and staging. Hepatology 1994; 19: 1513–1520

    CrossRef  CAS  PubMed  Google Scholar 

  9. Gaiani, S., Gramantieri, L., Venturoli, N., Piscaglia, F., Siringo, S., D’Errico, A., Zironi, G., Grigioni, W., Bolondi, L.: What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J. Hepatol. 1997; 27: 979–985

    CrossRef  CAS  PubMed  Google Scholar 

  10. Gerber, M.A., Vernace, S.: Chronic septal hepatitis. Virchows Archiv 1974; 363: 303–309

    CAS  Google Scholar 

  11. Goldin, R.D., Goldin, J.G., Burt, A.D., Dhillon, P.A., Hubscher, S., Wyatt, J., Patel, N.: Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J. Hepatol. 1996; 25: 649–654

    CrossRef  CAS  PubMed  Google Scholar 

  12. Hodges, J.R., Millvard-Sadler, G.H., Wright, R.: Chronic active hepatitis: the spectrum of disease. Lancet 1982/I: 550–552

    Google Scholar 

  13. Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R.N.M., Phillips, M.J., Portmann, B.G., Poulsen, H., Scheuer, P.J., Schmid, M., Thaler, H.: Histological grading and staging of chronic hepatitis. J. Hepatol. 1995; 22: 696–699

    CrossRef  CAS  PubMed  Google Scholar 

  14. Ishak, K.G.: Pathologic features of chronic hepatitis — A review and update. Amer. J. Clin. Path. 2000; 113: 40–55

    CAS  Google Scholar 

  15. Knodell, R.G., Ishak, K.G., Black, W.C., Chen, T.S., Craig, R., Kaplowitz, N., Kiernan, T.W., Wollman, J.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–435

    CAS  PubMed  Google Scholar 

  16. Korb, G.: Chronic hepatitis B virus and hepatitis C virus infection. Histology, classification, examination. Pathologe 2001; 22: 124–131

    CrossRef  CAS  PubMed  Google Scholar 

  17. Krastev, Z.: Liver damage score: a new index for evaluation of the severity of chronic liver diseases. Hepato-Gastroenterol. 1998; 45: 160–169

    CAS  Google Scholar 

  18. Kuntz, E., Kühn, H.A.: Systematik und Klinik der chronischen Hepatitis. Med. Klin. 1969; 64: 2227–2241

    CAS  PubMed  Google Scholar 

  19. Lashner, B.A., Jonas, R.B., Tang, H.-S., Evans, A.A., Ozeran, S.E., Baker, A.L.: Chronic hepatitis: disease factor at diagnosis predictive of mortality. Amer. J. Med. 1988; 85: 609–614

    CAS  PubMed  Google Scholar 

  20. Ludwig, J.: The nomenclature of chronic active hepatitis: an orbituary. Gastroenterology 1993; 105: 274–278

    CAS  PubMed  Google Scholar 

  21. Rozario, R., Ramakrishna, B.: Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J. Hepatol. 2003; 38: 223–229

    CrossRef  PubMed  Google Scholar 

  22. Scheuer, P.J.: Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 1991; 13: 372–374

    CrossRef  CAS  PubMed  Google Scholar 

  23. Schmid, M., Flury, R., Bühler, H., Havelka, J., Grob, P.J., Heitz, Ph.U.: Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis. Virchows Archiv 1994; 425:221–228

    CAS  PubMed  Google Scholar 

  24. Selmair, H., Vido, I., Wildhirt, E., Ortmans, H.: Die chronisch-nekrotisierende Hepatitis. Dtsch. Med. Wschr. 1970; 95: 1397–1401

    CAS  PubMed  Google Scholar 

  25. Soresi, M., Bonfissuto, G., Magliarisi, C., Riili, A., Terranova, A., di Giovanni, G., Bascone, F., Carroccio, A., Tripi, S., Montalto, G.: Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis. Clin. Radiol. 2003; 58: 372–377

    CrossRef  CAS  PubMed  Google Scholar 

  26. Thaler, H.: Systematische, morphologische und klinische Probleme der chronischen Hepatitis. Internist 1973; 14: 604–614

    CAS  PubMed  Google Scholar 

Chronic hepatitis A

  1. Inoue, K., Yoshiba, M., Yotsuyanagi, H., Otsuka, T., Sekiyama, K., Fujita, R.: Chronic hepatitis A with persistent viral replication. J. Med. Virol. 1996; 50: 322–324

    CrossRef  CAS  PubMed  Google Scholar 

Chronic hepatitis B

  1. Abdelmalek, M.F., Pasha, T.M., Zein, N.N., Persing, D.H., Wiesner, R.H., Douglas, D.D.: Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Liver transplant. 2003; 9: 1253–1257

    Google Scholar 

  2. Bonino, F., Rosina, F., Rizzetto, M., Rizzi, R., Chiaberge, E., Tardanico, R., Callea, F., Verme, G.: Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90:1268–1273

    CAS  PubMed  Google Scholar 

  3. Bonino, F., Brunetto, M.R.: Chronic hepatitis e antigen (HbeAg) negative, anti-Hbe positive hepatitis B: an overview. J. Hepatol. 2003; 39(Suppl. 1): 160–163

    Google Scholar 

  4. Bortolotti, F., Cadrobbi, P., Crivellaro, C., Guido, M., Rugge, M., Noventa, F., Calzia, R., Realdi, G.: Long-term outcome of chronic type hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990; 99: 805–810

    CAS  PubMed  Google Scholar 

  5. Chang, M.H.: Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Internat. 2003; 23: 309–314

    Google Scholar 

  6. Choi, M.S., Lee, J.H., Koh, K.C., Paik, S.W., Rhee, P.L., Kim, J.J., Rhee, J.C., Choi, K.W., Kim, S.H.: Clinical significanca of enlarged perihepatic lymph nodes in chronic hepatitis B. J. Clin. Gastroenterol. 2001; 32: 329–332

    CrossRef  CAS  PubMed  Google Scholar 

  7. Chu, C.M.: Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2000; 15(Suppl.) 25–30

    CrossRef  Google Scholar 

  8. Demirdag, K., Yilmaz, S., Ozdarendeli, A., Ozden, M., Kalkan, A., Kilic, S.S.: Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepato-Gastroenterol. 2003; 50: 766–770

    CAS  Google Scholar 

  9. Dohmen, K., Shigematsu, H., Irie, K., Ishibashi, H.: Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepato-Gastroenterol. 2003; 50: 2022–2027

    Google Scholar 

  10. Fattovich, G., Brollo, L., Giustina, G., Noventa, F., Pontisso, P., Alberti, A., Realdi, G., Ruol, A.: Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294–298

    CAS  PubMed  Google Scholar 

  11. Gambichler, T., Paech, V., Rotterdam, S., Stücker, M., Boms, S., Altmeyer, P.: Hepatitis B-associated adult-onset Still’s disease presentling with neutrophilic urticaria. Eur. J. Med. Res. 2003; 8: 527–530

    CAS  PubMed  Google Scholar 

  12. Hao, J.H., Shi, J., Ren, W.H., Han, G.Q., Zhu, J.R., Wang, S.Y., Xie, Y.B.: Hepatic microcirculatory disturbances in patients with chronic hepatitis B. Chin. Med. J. 2002; 115: 65–68

    PubMed  Google Scholar 

  13. Huo, T.L., Wu, J.C., Lee, P.C., Tsay, S.H., Chang, F.Y., Lee, S.D.: Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J. Clin. Gastroenterol. 2000; 30: 250–254

    CrossRef  CAS  PubMed  Google Scholar 

  14. Huo, T.L., Wu, J.C., Hwang, S.J., Lai, C.R., Lee, P.C., Tsay, S.H., Chang, F.Y., Lee, S.D.: Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study. Europ. J. Gastroenterol. Hepatol. 2000; 12: 687–693

    CAS  Google Scholar 

  15. Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S.: Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J. Clin. Microbiol. 2002; 40: 1207–1209

    PubMed  Google Scholar 

  16. Lee, H.-S., Yang, P.-M., Liu, B.-F., Lee, C.-L., Hsu, H.-C., Su, I.-J., Chen, D.-S.: Pleural effusion coinciding with acute exacerbations in a patient with chronic hepatitis B. Gastroenterology 1989; 96: 1604–1606

    CAS  PubMed  Google Scholar 

  17. Liaw, Y.-F., Tai, D.-I., Chu, C.-M., Lin, D.-Y., Sheen, I.-S., Chen, T.-J., Pao, C.C.: Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 1986; 90: 263–267

    CAS  PubMed  Google Scholar 

  18. Maruyama, T., Schödel, F., Iino, S., Koike, K., Yasuda, K., Peterson, D., Milich, D.R.: Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 1994; 106: 1006–1015

    CAS  PubMed  Google Scholar 

  19. Mason, A., Wick, M., White, H., Perrillo, R.: Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 1993; 18: 781–789

    CAS  PubMed  Google Scholar 

  20. McMahon, B.J.: The natural history of chronic hepatitis B virus infection. Semin. Liver Dis. 2004; 24(Suppl.): 17–21

    PubMed  Google Scholar 

  21. Merican, I., Guan, R., Amarapuka, D., Alexander, M.J., Chutaputti, A., Chien, R.N., Hasnian, S.S., Leung, N., Lesmana, L., Phiet, P.H., Noer, H.M.S., Sollano, J., Sun, H.S., Xu, D.Z.: Chronic hepatitis B virus infection in Asian countries. J. Gastroenterol. Hepatol. 2000; 15: 1356–1361

    CrossRef  CAS  PubMed  Google Scholar 

  22. Moreno-Otero, R., Garcia-Monzon, C., Garcia-Sanchez, A., Garcia-Buey, L., Pajares, J.M., Di Bisceglie, A.M.: Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBe Ag-positive asymptomatic patients. Amer. J. Gastroenterol. 1991; 86; 560–564

    CAS  Google Scholar 

  23. Myers, R.P., Tainturier, M.H., Ratziu, V., Piton, A., Thibault, V., Imbert-Bismut, F., Messous, D., Charlotte, F., di Martino, V., Benhamou, Y., Poynard, T.: Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J. Hepatol. 2003; 39: 222–230

    CrossRef  CAS  PubMed  Google Scholar 

  24. Ohata, K., Hamasaki, K., Toriyama, K., Ishikawa, H., Nakao, K., Eguchi, K.: High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 2004; 19: 670–675

    CrossRef  PubMed  Google Scholar 

  25. Ohlen, J., Liegl, J.M., Selmair, H.: Die Langzeitprognose chronischer Virus B-und Virus-C-Hepatitiden. Wartenberg-Studie (1974–1994). Leber Magen Darm 1995; 25: 205–210

    CAS  PubMed  Google Scholar 

  26. Peng, J., Luo, K.X., Zhu, Y.F., Guo, Y.B., Zhang, L., Hou, J.L.: Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen. Chin. Med. J. 2003; 116: 1312–1317

    PubMed  Google Scholar 

  27. Pollicino, T., Squadrito, G., Cerenzia, G., Cacciola, I., Raffa, G., Craxi, A., Farinati, F., Missale, G., Smedile, A., Tiribelli, C., Villa, E., Raimondo, G.: Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126: 102–110

    CrossRef  CAS  PubMed  Google Scholar 

  28. Roche, B., Feray, C., Gigou, M., Roque-Alfonso, A.M., Arulnaden, J.L., Delvart, V., Dussaix, E., Guettier, C., Bismuth, H., Samuel, D.: HBV DNA persistence 10 years after liver transplantation despite successful anti-HBs passive immunoprophylaxis. Hepatology 2003; 38: 86–95

    CrossRef  PubMed  Google Scholar 

  29. Schalm, S.W., Thomas, H.C., Hadziyannis, S.J.: Chronic hepatitis B. Prog. Liver Dis. 1990; 9: 443–462

    CAS  PubMed  Google Scholar 

  30. Stemerowicz, R., Möller, B., Lobeck, H., Oertel, J., Hopf, U.: Schoenlein-Henoch-Purpura with HBsAg-positive chronic hepatitis. Immun. Infekt. 1988; 16: 12–15

    CAS  PubMed  Google Scholar 

  31. Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M., Saisho, H.: Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003; 37: 19–26

    CrossRef  CAS  PubMed  Google Scholar 

  32. Tang, B.Q., Kruger, W.D., Chen, G., Shen, F.M., Lin, W.Y., Mboup, S., London, W.T., Evans, A.A.: Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers. J. Med. Virol. 2004; 72: 35–40

    CAS  PubMed  Google Scholar 

  33. Tsai, J.-F., Chang, W.-Y., Jeng, J.-E., Ho, M.-S., Lin, Z.-Y., Tsai, J.-H.: Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994; 14: 98–102

    CAS  PubMed  Google Scholar 

  34. Vegnente, A., Iorio, R., Guida, S., Cimmino, L.: Chronicity rate of hepatitis B virus infection in the families of 60 hepatitis B surface antigenpositive chronic carrier children: role of horizontal transmission. Europ. J. Pediatr. 1992; 151: 188–191

    CAS  Google Scholar 

  35. Wang, H.C., Wu, H.C., Chen, C.F., Fausto, N., Lei, H.Y., Su, I.J.: Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Amer. J. Path. 2003; 163: 2441–2449

    CAS  PubMed  Google Scholar 

  36. Weissberg, J.I., Andres, L.L., Smith, C.I., Weick, S., Nichols, J.E., Garcia, G., Robinson, W.S., Merigan, T.C., Gregory, P.B.: Survival in chronic hepatitis B. An analysis of 379 patients. Ann. Intern. Med. 1984; 101: 613–616

    CAS  PubMed  Google Scholar 

  37. Yeo, W., Chan, P.K.S., Hui, P., Ho, W.M., Lam, K.C., Kwan, W.H., Zhong, S., Johnson, P.J.: Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. J. Med. Virol. 2003; 70: 553–561

    CrossRef  PubMed  Google Scholar 

  38. You, S.L., Yang, H.I., Chen, C.J.: Seropositivity of hepatitis B e antigen and hepatocellular carcinoma. Ann. Med. 2004; 36: 215–224

    CAS  PubMed  Google Scholar 

  39. Yuen, M.F., Sablon, E., Wong, D.K.H., Yuan, H.J., Wong, B.C.Y., Chan, A.O.O., Lai, C.L.: Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin. Infect. Dis. 2003; 37: 593–597

    CrossRef  PubMed  Google Scholar 

Chronic hepatitis C

  1. Agnello, V., de Rosa, F.G.: Extrahepatic disease manifestations of HCV infection: some current issues (review). J. Hepatol. 2004; 40: 341–552

    CrossRef  PubMed  Google Scholar 

  2. Alter, H.J., Seeff, L.B.: Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 2000; 20: 17–35

    CrossRef  CAS  PubMed  Google Scholar 

  3. Antonelli, A., Ferri, C., Pampana, A., Fallahi, P., Nesti, C., Pasquini, M., Marchi, S., Ferrannini, E.: Thyroid disorders in chronic hepatitis C. Amer. J. Med. 2004; 117: 10–13

    CAS  PubMed  Google Scholar 

  4. Bain, V.G., Bonacini, M., Govindarajan, S., Ma, M., Sherman, M., Gibas, A., Cotler, S.J., Deschenes, M., Kaita, K., Ihangri, G.S.: A ulticentre study of the usefulness of liver biopsy in hepatitis C. J. Viral Hepat. 2004; 11: 375–382

    CrossRef  CAS  PubMed  Google Scholar 

  5. Bedossa, P., Bioulac-Sage, P., Callard, P., Chevallier, M., Degott, C., Deugnier, Y., Fabre, M., Reynés, M., Voigt, J.J., Zafrani, E.S.: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15–20

    Google Scholar 

  6. Bedossa, P., Poynard, T.: An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289–293

    CAS  PubMed  Google Scholar 

  7. Bedossa, P., Dargere, D., Paradis, V.: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449–1457

    PubMed  Google Scholar 

  8. Berenguer, M., Prieto, M., Rayon, J.M., Mora, J., Pastor, M., Ortiz, V., Carrasco, D., San-Juan, F., Burgueno, M.D.J., Mir, J., Berenguer, J.: Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32: 852–858

    CAS  PubMed  Google Scholar 

  9. Bonnet, F., Morlat, P., Dubuc, J., de Witte, S., Bonarek, M., Bernard, N., Lacoste, D., Beylot, J.: Sarcoidosis-associated hepatitis virus infection (case report). Dig. Dis. Sci. 2002; 47: 794–796

    CrossRef  CAS  PubMed  Google Scholar 

  10. Cassani, F., Cataleta, M., Valentini, P., Muratori, P., Giostra, F., Francesconi, R., Muratori, L., Lenzi, M., Bianchi, G., Zauli, D., Bianchi, F.B.: Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26: 561–566

    CAS  PubMed  Google Scholar 

  11. Crespo, J., Rivero, M., Fabrega, E., Cayon, A., Amado, J.A., Garcia-Unzeta, M.T., Pons-Romero, F.: Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig. Dis. Sci. 2002; 47: 1604–1610

    CrossRef  CAS  PubMed  Google Scholar 

  12. Crowson, A.N., Nuovo, G., Ferri, C., Magro, C.M.: The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessments of 35 cases. Hum. Pathol. 2003; 34: 573–579

    PubMed  Google Scholar 

  13. Degos, F., Christidis, C., Ganne-Carrie, N., Farmachidi, J.P., Degott, C., Guettier, C., Trinchet, J.C., Beaugrand, M., Chevret, S.: Hepatitis C virus-related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131–136

    CrossRef  CAS  PubMed  Google Scholar 

  14. Dhillon, A.P., Dusheiko, G.M.: Pathology of hepatitis C virus infection. Histology 1995; 26: 297–309

    CAS  Google Scholar 

  15. Dietrich, C.F., Stryjek-Kaminska, D., Teuber, G., Lee, J.H., Caspary, W.F., Zeuzem, S.: Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection. Amer. J. Roentgenol. 2000; 174: 699–704

    CAS  Google Scholar 

  16. DiMartino, V., Rufat, P., Boyer, N., Renard, P., Degos, F., Martinot-Peignoux, M., Matheron, S., LeMoing, V., Vachon, F., Degott, C., Valla, D., Marcellin, P.: The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A longterm retrospective cohort study. Hepatology 2001; 34: 1193–1199

    CAS  Google Scholar 

  17. EASL International Consensus Conference on hepatitis C. Consensus statement. J. Hepatol. 1999; 30: 956–961

    Google Scholar 

  18. Erhardt, A., Hauck, K., Häussinger, D.: Iron as comorbid factor in chronic hepatitis. Med. Klin. 2003; 98: 685–691

    CrossRef  CAS  Google Scholar 

  19. Farinati, F., Cardin, R., de Maria, N., della Libera, G., Marafin, C., Lecis, E., Burra, P., Floreani, A., Cecchetto, A., Naccarato, R.: Iron storage, lipid peroxidation and glutathion turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 1995; 22: 449–456

    CrossRef  CAS  PubMed  Google Scholar 

  20. Floreani, A., Baragiotta, A., Leone, M.G., Baldo, V., Naccarato, R.: Primary biliary cirrhosis and hepatitis C virus infection. Amer. J. Gastroenterol. 2003; 98: 2757–2762

    Google Scholar 

  21. Forton, D.M., Taylor-Robinson, S.D., Thomas, H.C.: Cerebral dysfunction in chronic hepatitis C infection (review). J. Viral Hepat. 2003; 10: 81–86

    CrossRef  CAS  PubMed  Google Scholar 

  22. Foster, G.R., Goldin, R.D., Thomas, H.C.: Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209–212

    CrossRef  CAS  PubMed  Google Scholar 

  23. Fried, M.W., Draguesku, J.O., Shindo, M., Simpson, L.H., Banks, S.M., Hoofnagle, J.H., Di Bisceglie, A.M.: Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig. Dis. Sci. 1993; 38: 631–636

    CrossRef  CAS  PubMed  Google Scholar 

  24. Gane, E.J., Portmann, B.C., Naoumov, N.V., Smith, H.M., Underhill, J.A., Donaldson, P.T., Maertens, G., Williams, R.: Long-term outcome of hepatitis C infection after liver transplantation. New Engl. J. Med. 1996; 334: 815–820

    CrossRef  CAS  PubMed  Google Scholar 

  25. Gebo, K.A., Herlong, H.F., Torbenson, M.S., Jenckes, M.W., Chander, G., Ghanem, K.G., El-Kamary, S.S., Sulkowski, M., Bass, E.B.: Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36(Suppl.): 161–172

    Google Scholar 

  26. Ghany, M.G., Kleiner, D.E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T.J., Hoofnagle, J.H.: Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003; 124: 97–114

    CrossRef  PubMed  Google Scholar 

  27. Gisbert, J.P., Garcia-Buey, L., Pajares, J.M., Moreno-Otero, R.: Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematik review and meta-analysis. Gastroenterology 2003; 125: 1723–1732

    CrossRef  PubMed  Google Scholar 

  28. Gronbaek, K., Christensen, P.B., Hamilton-Dutoit, S., Federspiel, B.H., Hage, E., Jensen, O.J., Vyberg, M.: Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C. J. Viral Hepat. 2002; 9: 443–449

    CrossRef  CAS  PubMed  Google Scholar 

  29. Hatano, R., Ebara, M., Fukuda, H., Yoshikawa, M., Sugiura, N., Kondo, F., Yukawa, M., Saisho, H.: Accumulation of copper in the liver and hepatic injury in chronic hepatitis C. J. Gastroenterol. 2000; 15: 786–791

    CAS  Google Scholar 

  30. Hezode, C., Lonjon, I., Roudot-Thoraval, F., Mavier, J.P., Pawlotsky, J.M., Zafrani, E.S., Dhumeaux, D.: Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003; 52: 126–129

    CrossRef  CAS  PubMed  Google Scholar 

  31. Hickman, I.J., Powell, E.E., Prins, J.B., Clouston, A.D., Ash, S., Purdie, D.M., Jonsson, J.R.: In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J. Hepatol. 2003; 39: 1042–1048

    CrossRef  CAS  PubMed  Google Scholar 

  32. Hilsabeck, R.C., Perry, W., Hassanein, T.I.: Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440–446

    CrossRef  PubMed  Google Scholar 

  33. Hu, K.Q., Kyulo, N.L., Esrailian, E., Thompson, K., Chase, R., Hillebrand, D.J., Runyon, B.A.: Overweight and obesity, hepatic steatosis and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J. Hepatol. 2004; 40: 147–154

    CrossRef  CAS  PubMed  Google Scholar 

  34. Hui, J.M., Sud, A., Farrell, G.C., Bandara, P., Byth, K., Kench, J.G., McCaughan, G.W., George, J.: Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003; 125: 1695–1704

    CrossRef  CAS  PubMed  Google Scholar 

  35. Idilman, R., Colantoni, A., de Maria, N., Alkan, S., Nand, S., van Thiel, D.H.: Lymphoproliferative disorders in chronic hepatitis C. J. Viral Hepat. 2004; 11: 302–309

    CAS  PubMed  Google Scholar 

  36. Ierna, D., D’Amico, R.A., Antoci, S., Campanile, E., Neri, S.: Perihepatic lymphadenopathy in chronic hepatitis C: a complementary diagnostic element? J. Gastroenterol. 2000; 15: 783–785

    CAS  Google Scholar 

  37. Imazeki, F., Yokosuka, O., Fukai, K., Hiraide, A., Saisho, H.: Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C. Dig. Dis. Sci. 2003; 48: 1786–1792

    CrossRef  PubMed  Google Scholar 

  38. Jara, P., Resti, M., Hierro, L., Giacchino, R., Barbera, C., Zancan, L., Crivellaro, C., Sokal, E., Azzari, C., Guido, M., Bortolotti, F.: Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin. Infect. Dis. 2003; 36: 275–280

    CrossRef  PubMed  Google Scholar 

  39. Jarmay, K., Karacsony, G., Ozsvar, Z., Lonovics, J., Schaff, Z.: Assessment of histological features in chronic hepatitis C. Hepato-Gastroenterol. 2002; 49: 239–243

    Google Scholar 

  40. Kramer, L., Bauer, E., Funk, G., Hofer, H., Jessner, W., Steindl-Munda, P., Wrba, F., Madl, C., Gangl, A., Ferenci, P.: Subclinical impairment of brain function in chronic hepatitis C infection. J. Hepatol. 2002; 37: 349–354

    CrossRef  PubMed  Google Scholar 

  41. Leone, N., Pellicano, R., Maiocco, I.A., Modena, V., Marietti, G., Rizzetto, M., Ponzetto, A.: Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. J. Med. Virol. 2002; 66: 200–203

    CrossRef  CAS  PubMed  Google Scholar 

  42. Martinelli, A.L.C., Villanova, M.G., Roselino, A.M.F., Figueiredo, J.F.C., Pasos, A.D.C., Covas, D.T., Zucoloto, S.: Abnormal uroporphyrin levels in chronic hepatitis C virus infection. J. Clin. Gastroenterol. 1999; 29: 327–331

    CrossRef  CAS  PubMed  Google Scholar 

  43. McCaughan, G.W., George, J.: Fibrosis progression in chronic hepatitis C virus infection. Gut 2004; 53: 318–321

    CrossRef  CAS  PubMed  Google Scholar 

  44. McCormick, S.E., Goodman, Z.D., Maydonovitch, C.L., Sjogren, M.H.: Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Amer. J. Gastroenterol. 1996; 91: 1516–1522

    CAS  Google Scholar 

  45. McHutchison, J.G., Blatt, L.M., de Medina, M., Graig, J.R., Conrad, A., Schiff, E.R., Tong, M.J.: Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. J. Gastroenterol. Hepatol. 2000; 15: 945–951

    CrossRef  CAS  PubMed  Google Scholar 

  46. Medina, J., Garcia-Buey, L., Moreno-Otero, R.: Review article: Hepatitis C virus-related extra-hepatic disease. Aetiopathogenesis and management. Alim. Pharm. Ther. 2004; 20: 129–141

    CAS  Google Scholar 

  47. Memon, M.I., Memon, M.A.: Hepatitis C: an epidemiological review. J. Viral Hepat. 2002; 9: 84–100

    CrossRef  CAS  PubMed  Google Scholar 

  48. Merican, I., Sherlock, S., McIntyre, N., Dusheiko, G.M.: Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Quart. J. Med. 1993; 86: 119–125

    CAS  PubMed  Google Scholar 

  49. Moriyama, M., Matsumura, H., Shimizu, T., Shioda, A., Kaneko, M., Saito, H., Miyazawa, K., Tamaka, N., Sugitani, M., Komiyama, K., Arakawa, Y.: Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C. Liver 2000; 20: 397–404

    CAS  PubMed  Google Scholar 

  50. Muller, P., Renou, C., Harafa, A., Jouve, E., Kaplanski, G., Ville, E., Bertrand, J.J., Masson, C., Benderitter, T., Halfon, P.: Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host. J. Hepatol. 2003; 39: 807–813

    CrossRef  PubMed  Google Scholar 

  51. Ohoka, S., Tanaka, Y., Amako, Y., Kohara, M., Ishidate, K., Watanabe, M., Takahashi, Y., Sato, C.: Sialadenitis in patients with chronic hepatitis C is not directly related to hepatitis C virus. Hepatol. Res. 2003; 27: 23–29

    PubMed  Google Scholar 

  52. Ortiz, V., Berenguer, M., Rayon, J.M., Carrasco, D., Berenguer, J.: Contribution of obesity to hepatitis C-related fibrosis progression. Amer. J. Gastroenterol. 2002; 97: 2408–2414

    Google Scholar 

  53. Pawlotsky, J.-M., Roudot-Thoraval, F., Simmonds, P., Mellor, J., Ben Yahia, M., André, C., Voisin, M.-C., Intrator, L., Zafrani, E.-S., Duval, J., Dhumeaux, D.: Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann. Intern. Med. 1995; 122: 169–173

    CAS  PubMed  Google Scholar 

  54. Pianko, S., Patella, S., Sievert, W.: Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection. J. Gastroenterol. 2000; 15: 798–805

    CAS  Google Scholar 

  55. Piche, T., Gelsi, E., Schneider, S.M., Hebuterne, X., Giudicelli, J., Ferrua, B., Laffout, C., Benzaken, S., Hastier, P., Montoya, M.L., Longo, F., Rampal, P., Tran, A.: Fatigue is associated with circulating leptin levels in chronic hepatitis C. Gut 2002; 51: 434–439

    CrossRef  CAS  PubMed  Google Scholar 

  56. Piche, T., Vandenbos, F., Abakar-Mahamat, A., Vanbiervliet, G., Barjoan, E.M., Calle, G., Giudicelli, J., Ferrua, B., Laffont, C., Benzaken, S., Tran, A.: The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J. Viral Hepat. 2004; 11: 91–96

    CrossRef  CAS  PubMed  Google Scholar 

  57. Poynard, T., Bedossa, P., Opolon, P.: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825–832

    CrossRef  CAS  PubMed  Google Scholar 

  58. Poynard, T., Cacoub, P., Ratzin, V., Myers, R.P., Dezailles, M.H., Mercadier, A., Ghillani, P., Charlotte, F., Piette, J.C., Moussalli, J.: Fatigue in patients with chronic hepatitis C. J. Viral Hepat. 2002; 9: 295–303

    CAS  PubMed  Google Scholar 

  59. Pradat, P., Alberti, A., Poynard, T., Esteban, J.-I., Weiland, O., Marcellin, P., Badalamenti, S., Trepo, C.: Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology 2002; 36: 973–977

    PubMed  Google Scholar 

  60. Razonable, R.R., Burak, K.W., van Cruijsen, H., Brown, R.A., Charlton, M.R., Smith, T.F., Espy, M.J., Kremers, W., Wilson, J.A., Groettum, C., Wiesner, R., Paya, C.V.: The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin. Inf. Dis. 2002; 35: 974–981

    CrossRef  Google Scholar 

  61. Regev, A., Berho, M., Jeffers, L.J., Milikowski, C., Molina, E.G., Pyrsopoulos, N.T., Feng, Z.Z., Reddy, K.R., Schiff, E.R.: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Amer. J. Gastroenterol. 2002; 97: 2614–2618

    Google Scholar 

  62. Rigamonti, C., Mottaran, E., Reale, E., Rolla, R., Cipriani, V., Capelli, F., Boldorini, R., Vidali, M., Sartori, M., Albano, E.: Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003; 38: 42–49

    CrossRef  CAS  PubMed  Google Scholar 

  63. Romero-Gomez, M., Grande, L., Nogales, M.C., Fernandez, M., Chavez, M., Castro, M.: Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption. Dig. Dis. Sci. 2001; 33: 698–702

    CAS  Google Scholar 

  64. Ross, R.S., Viazov, S., Gross, T., Hormann, F., Seipp, H.-M., Roggendorf, M.: Transmission of hepatitis C virus from a patient to an anaesthesiology assistant to five patients. New Engl. J. Med. 2000; 343: 1851–1854

    CAS  PubMed  Google Scholar 

  65. Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.J., Mentha, G., Spahr, L., Zarski, J.P., Borisch, B., Hadengue, A., Negro, F.: Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype J. Hepatol. 2000; 33: 106–115

    CAS  Google Scholar 

  66. Sanchez-Pobre, P., Gonzalez, C., Paz, E., Colina, F., Castellano, G., Munoz-Yague, T., Rodriguez, S., Yela, C., Alvarez, V., Solis-Herruzo, J.: Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. Dig. Dis. Sci. 2002; 47: 1224–1229

    PubMed  Google Scholar 

  67. Sartori, M., Andorno, S., La Terra, G., Boldorini, R., Leone, F., Pi Hau, S., Zecchina, G., Aglietta, M., Saglio, G.: Evaluation of iron status in patients with chronic hepatitis C. Ital. J. Gastroenterol. Hepatol. 1998; 30: 396–401

    CAS  PubMed  Google Scholar 

  68. Scheuer, P.J., Krawczynski, K., Dhillon, A.P.: Histopathology and detection of hepatitis C virus in liver. Semin. Immunpathol. 1997; 19: 27–45

    CAS  Google Scholar 

  69. Serfaty, L., Chazouillères, O., Poujol-Robert, A., Morand-Joubert, L., Dubois, C., Chrétien, Y., Poupon, R.E., Petit, J.-C., Poupon, R.: Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology 1997; 26: 776–779

    CAS  PubMed  Google Scholar 

  70. Shakil, A.O., Conry-Cantilena, C., Alter, H.J., Hayashi, P., Kleiner, D.E., Tedeschi, V., Krawczynski, K., Conjeevaram, H.S., Sallie, R., DiBisceglie, A.M.: Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann. Intern. Med. 1995; 123: 330–337

    CAS  PubMed  Google Scholar 

  71. Siddique, I., Abu-El-Naga, H., Madda, J.P., Memon, A., Hasan, F.: Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand. J. Gastroenterol. 2003; 38: 427–432

    CAS  PubMed  Google Scholar 

  72. Silva, I.S.S., Ferraz, M.L.C.G., Perez, R.M., Lanzoni, V.P., Figueiredo, V.M., Silva, A.E.B.: Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 2003; 19: 314–318

    Google Scholar 

  73. Tong, M.J., El-Farra, N.S., Reikes, A.R., Co, R.L.: Clinical outcomes after transfusion-associated hepatitis C. New Engl. J. Med. 1995; 332: 1463–1466

    CrossRef  CAS  PubMed  Google Scholar 

  74. Trendelenburg, M., Schifferli, J.A.: Cryoglobulins in chronic hepatitis C virus infection. Clin. Exper. Immunol. 2003; 133: 153–155

    CAS  Google Scholar 

  75. Vento, S., Garofano, T., Renzini, C., Cainelli, F., Casali, F., Ghironzi, G., Ferraro, T., Concia, E.: Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New Engl. J. Med. 1998; 338: 286–290

    CrossRef  CAS  PubMed  Google Scholar 

  76. Verbaan, H., Widell, A., Lindgren, S., Lindmark, B., Nordenfelt, E., Eriksson, S.: Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J. Intern. Med. 1992; 232: 33–42

    CAS  PubMed  Google Scholar 

  77. Wedemeyer, H., Ockenga, J., Frank, H., Tillmann, H.L., Schuler, A., Caselitz, M., Gebel, M., Trautwein, C., Manns, M.P.: Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis C. Hepato-Gastroenterol. 1998; 45: 1062–1068

    CAS  Google Scholar 

  78. Westin, J., Lagging, L.M., Spak, F., Aires, N., Svensson, E., Lindh, M., Dhillon, A.P., Norkrans, G., Wejstal, R.: Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J. Viral Hepat. 2002; 9: 235–241

    CrossRef  PubMed  Google Scholar 

  79. Zarski, J.P., McHutchinson, J., Bronowicki, J.P., Sturm, N., Garcia-Kennedy, R., Hoday, E., Truta, B., Wright, T., Gish, R.: Rate of natural disease progression in patients with chronic hepatitis C. J. Hepatol. 2003; 38: 307–314

    CrossRef  PubMed  Google Scholar 

  80. Zein, N.N., Arslan, M., Li, H.J., Charlton, M.R., Gross, J.B., Poterucha, J.J., Therneau, T.M., Kolbert, C.P., Persing, D.H.: Clinical significance of TT virus infection in patients with chronic hepatitis C. Amer. J. Gastroenterol. 1999; 94: 3020–3027

    CAS  Google Scholar 

  81. Zhang, X.M., Mitchell, D.G., Shi, H.Y., Holland, G.A., Parker, L., Herrine, S.K., Pasqualin, D., Rubin, R.: Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging. Amer. J. Roentgenol. 2002; 179: 417–422

    Google Scholar 

Chronic hepatitis D

  1. Ackerman, Z., Valinluck, B., McHutchison, J.G., Redeker, A.G., Govindarajan, S.: Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: the role of hepatitis B, C or D? Hepatology 1992; 16: 625–629

    CAS  PubMed  Google Scholar 

  2. Elefsiniotis, I.S., Diamantis, I.D., Dourakis, S.P., Kafiri, G., Pantazis, K., Mavrogiannis, C.: Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis. Eur. J. Gastroenterol. Hepatol. 2003; 15: 721–726

    CAS  PubMed  Google Scholar 

  3. Gerken, G., Meyer zum Büschenfelde, K.-H.: Chronic hepatitis delta virus (HDV) infection. Hepato-Gastroenterol. 1991; 38: 29–32

    CAS  Google Scholar 

  4. Philipp, T., Durazzo, M., Trautwein, C., Alex, B., Straub, P., Lamb, J.G., Johnson, E.F., Tukey, R.H., Manns, M.P.: Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet 1994; 344: 578–581

    CrossRef  CAS  PubMed  Google Scholar 

Therapy of chronic hepatitis B

  1. Alexander, G.J.M., Fagan, E.A., Hegarty, J.E., Yeo, J., Eddlestone, A.L.W.F., Williams, R.: Controlled trial of acyclovir in chronic hepatitis B virus infection. J. Med. Virol. 1987; 21: 81–87

    CAS  PubMed  Google Scholar 

  2. Bartholomeusz, A., Groenen, L.C., Locarnini, S.A.: Clinical experience with famciclovir against hepatitis B virus. Intervirology 1997; 40: 337–342

    CAS  PubMed  Google Scholar 

  3. Ben-Ari, Z., Mor, E., Tur-Kaspa, R.: Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature. J. Intern. Med. 2003; 253: 544–552

    CrossRef  CAS  PubMed  Google Scholar 

  4. Bryant, M.L., Bridges, E., Placidi, L., Faray, A., Loi, A.-G., Pierra, C., Dukhan, D., Gosselin, G., Imbach, J.-L., Hernandez, B., Juodawlkis, A., Tennant, B., Korba, B., Cote, P., Marion, P., Cretton-Scott, E., Schinazi, R.F., Sommadossi, J.-P.: Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrob. Agents Chemother. 2001; 45: 229–235

    CrossRef  CAS  PubMed  Google Scholar 

  5. Chan, H.L.Y., Tang, J.L., Tam, W., Sung, J.J.Y.: The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a metaanalysis. Alim. Pharm. Ther. 2001; 15: 1899–1905

    CAS  Google Scholar 

  6. Chen, C., Guo, S.M., Liu, B.: A randomized controlled trial of kurorinone versus interferon-α2a treatment in chronic hepatitis B. J. Viral Hepat. 2000; 7: 225–229

    CrossRef  CAS  PubMed  Google Scholar 

  7. Cooksley, W.G.E., Piratvisuth, T., Lee, S.D., Mahachai, V., Chao, Y.C., Tanwandee, T., Chutaputti, A., Chang, W.Y., Zahm, F.E., Pluck, N.: Peginterferon alpha-2a (40 k Da): An advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J. Viral. Hepat. 2003; 10: 298–305

    CrossRef  CAS  PubMed  Google Scholar 

  8. Crowley, S., Tognanni, D., Desmond, P., Lees, M., Saat, G.: Introduction of lamivudine for the treatment of chronic hepatitis B: expected clinical and economic outcomes based on 4-year clinical trial data. J. Gastroenterol. Hepatol. 2002; 17: 153–164

    CrossRef  CAS  PubMed  Google Scholar 

  9. Di Bisceglie, A.M., Fong, T.-L, Fried. M.W., Swain, M.G., Baker, B., Korenman, J., Bergasa, N.V., Waggoner, J.G., Park, Y., Hoofnagle, J.H.: A randomized, controlled trial of recombinant α-Interferon therapy for chronic hepatitis B. Amer. J. Gastroenterol. 1993; 88: 1887–1892

    Google Scholar 

  10. Dienstag, J.L., Goldin, R.D., Heathcote, E.J., Hann, H.W.L., Woessner, M., Stephenson, S.L., Gardner, S., Fraser-Gray, D., Schiff, E.R.: Histological outcome during long-term lamivudine therapy. Gastroenterology 2003; 124: 105–117

    CrossRef  CAS  PubMed  Google Scholar 

  11. Dienstag, J.L., Cianciara, J., Karayalcin, S., Kowdley, K.V., Willems, B., Plisek, S., Woessner, M., Gardner, S., Schiff, E.: Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology 2003; 37: 748–755

    CrossRef  CAS  PubMed  Google Scholar 

  12. Gaia, S., Marzano, A., Smedile, A., Barbon, V., Abate, M.L., Olivero, A., Lagget, M., Paganin, S., Fadda, M., Niro, G., Rizzetto, M.: Four years of treatment with lamivudine: Clinical and virological evaluations in Hbe antigen-negative chronic hepatitis B. Alim. Pharm. Ther. 2004; 20: 281–287

    CAS  Google Scholar 

  13. Genel, F., Unal, F., Ozgenc, F., Aksu, G., Aydogdu, S., Kutukculer, N., Yagci, R.V.: Decreased ratio of CD4 / CD8 lymphocytes might be predictive for successful interferon alpha and lamivudine combined therapy in childhood chronic hepatitis B infection: A preliminary study. J. Gastroenterol. Hepatol. 2003; 18: 645–650

    CrossRef  CAS  PubMed  Google Scholar 

  14. Gjorup, I.E., Skinhoj, P.: New aspects on the natural history of chronic hepatitis B infection: implication for therapy. Scand. J. Infect. Dis. 2003; 35: 808–813

    PubMed  Google Scholar 

  15. Guptan, R.C., Thakur, V., Kazim, S.N., Sarin, S.K.: Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients. J. Gastroenterol. Hepatol. 2002; 17: 765–771

    CrossRef  CAS  PubMed  Google Scholar 

  16. Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., Chang, T.T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S.G., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L.: Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. New Engl. J. Med. 2003; 348: 800–807

    CrossRef  CAS  PubMed  Google Scholar 

  17. Honkoop, P., de Man, R.A., Niesters, H.G.M., Zondervan, P.E., Schalm, S.W.: Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology 2000; 32: 635–639

    CrossRef  CAS  PubMed  Google Scholar 

  18. Hui, J.M., George, J., Liddle, C., Lin, R., Samarasinghe, D., Crewe, E., Farrell, G.C.: Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance. Amer. J. Gastroenterol. 2002; 97: 1003–1009

    CAS  Google Scholar 

  19. Krogsgaard, K.: The long-term effect of treatment with interferon-α2a in chronic hepatitis B. J. Viral Hepatit. 1998; 5: 389–397

    CAS  Google Scholar 

  20. Kweon, Y.O., Goodman, Z.D., Dienstag, J.L., Schiff, E.R., Brown, N.A., Burkhardt, E., Schoonhoven, R., Brenner, D.A., Fried, M.W.: Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J. Hepatol. 2001; 35: 749–755

    CrossRef  CAS  PubMed  Google Scholar 

  21. Lai, C.-L., Chien, R.-N., Leung, N.W.Y., Chang, T.-T., Guan, R., Tai, D.-I., Ng, K.-Y., Wu, P.-C., Dent, J.C., Barber, J., Stephenson, S.L., Gray, F.: A one-year trial of lamivudine for chronic hepatitis. New Engl. J. Med. 1998; 329: 61–68

    Google Scholar 

  22. Lai, C.L., Rosmawati, M., Lao, J., van Vlierberghe, H., Anderson, F.H., Thomas, N., Dehertogh, D.: Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 2002; 123: 1831–1838

    CrossRef  CAS  PubMed  Google Scholar 

  23. Lau, G.K.K., Nanji, A., Hou, J., Fong, D.Y.T., Au, W.S., Yuen, S.T., Lin, M., Kung, H.F., Lam, S.K.: Thymosin-alpha 1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. J. Viral Hepat. 2002; 9: 280–287

    CrossRef  CAS  PubMed  Google Scholar 

  24. Lau, G.K.K., Yiu, H.H.Y., Fong, D.Y.T., Cheng, H.C., Au, W.Y., Lai, L.S.F., Cheung, M., Zhang, H.Y., Lie, A., Ngan, R., Liang, R.: Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 2003; 125: 1742–1749

    CrossRef  CAS  PubMed  Google Scholar 

  25. Liaw, Y.F.: Hepatitis flares and hepatitis B e antigen seroconversion: implication in antihepatitis B virus therapy (review). J. Gastroenterol. Hepatol. 2003; 18: 246–252

    CAS  PubMed  Google Scholar 

  26. Lok, A.S.F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E.R., Dienstag, J.L., Heathcote, E.J., Little, N.R., Griffiths, D.A., Gardner, S.D., Castiglia, M.: Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003; 125: 1714–1722

    CrossRef  CAS  PubMed  Google Scholar 

  27. Lu, D.T.Y., Khokhar, M.F., Doo, E., Ghany, M.G., Herion, D., Park, Y., Kleiner, D.E., Schmid, P., Condreay, L.D., Gauthier, J., Kuhns, M.C., Liang, T.J., Hoofnagle, J.H.: Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 2000; 32: 828–834

    Google Scholar 

  28. Main, J., Brown, J.L., Howels, C., Galassini, R., Crossey, M., Karayiannis, P., Georgiou, P., Atkinson, G., Thomas, H.C.: A double-blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J. Viral Hepatit. 1996; 3: 211–215

    CAS  Google Scholar 

  29. Malaguarnera, M., Restuccia, S., Receputo, G., Giugno, I., Pistone, G., Trovato, B.A.: The efficacy of interferon alpha in chronic hepatitis B: a review and meta-analysis. Curr. Ther. Res. 1996; 57: 646–662

    CrossRef  CAS  Google Scholar 

  30. Marcellin, P., Chang, T., Lim, S.G., Tong, M.J., Sievert, W., Shiffman, M.L., Jeffers, L., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L.: Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. New Engl. J. Med. 2003; 348: 808–816

    CrossRef  CAS  PubMed  Google Scholar 

  31. Marcellin, P., Lau, G.K.K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., M., Gurel, S., Lai, M.Y., Button, P., Pluck, N.: Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAgnegative chronic hepatitis B. New Engl. J. Med. 2004; 351: 1206–1217

    CrossRef  CAS  PubMed  Google Scholar 

  32. Marques, A.R., Lau, D.T.Y., McKenzie, R., Straus, S.E., Hoofnagle, J.H.: Combination therapy with famciclovir and interferon-α for the treatment of chronic hepatitis B. J. Infect. Dis. 1998; 178: 1483–1487

    CrossRef  CAS  PubMed  Google Scholar 

  33. Mihm, U., Sarrazin, C., Herrmann, E., Teuber, G., von Wagner, M., Kronenberger, B., Zeuzem, S.: Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B. Z. Gastroenterol. 2003; 41: 249–254

    CrossRef  CAS  PubMed  Google Scholar 

  34. Munoz, R., Castellano, G., Fernandez, I., Alvarez, M.V., Manzano, M.L., Marcos, M.S., Cuenca, B., Solis-Herruzo, J.A.: A pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon. J. Hepatol. 2002; 37: 655–659

    CAS  PubMed  Google Scholar 

  35. Mutimer, D., Naoumov, N., Honkoop, P., Marinos, G., Ahmed, M., de Man, R., McPhillips, P., Johnson, M., Williams, R., Elias, E., Schalm, S.: Combination alpha-interferon and lamivudine therapy for alphainterferon resistant chronic hepatitis B infection: results of a pilot study. J. Hepatol. 1998; 28: 923–929

    CrossRef  CAS  PubMed  Google Scholar 

  36. Nevens, F., Main, J., Honkoop, P., Tyrrell, L., Barber, J., Sullivan, M.T., Fevery, J., de Man, R.A., Thomas, H.C.: Lamivudine therapy for chronic hepatitis B: a six-month randomised dose-ranging study. Gastroenterology 1997; 113: 1258–1263

    CrossRef  CAS  PubMed  Google Scholar 

  37. Niederau, C., Strohmeyer, G., Heintges, T., Peter, K., Gopfert, F.: Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multicenter, randomized, double-blind, placebo-controlled trial. Hepato-Gastroenterol. 1998; 45: 797–804

    CAS  Google Scholar 

  38. Oh, J.M., Kyun, J., Cho, S.W.: Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis. Pharmacotherapy 2002; 22: 1226–1234

    CAS  PubMed  Google Scholar 

  39. Ohkoshi, S., Ogata, N., Ichida, T.: The long-term clinical outcome of 1-year treatment of chronic hepatitis B with lamivudine-5 years observation. Hepatol. Res. 2003; 27: 13–17

    CAS  PubMed  Google Scholar 

  40. Perrillo, R., Hann, H.W., Mutimer, D., Willems, B., Leung, N., Lee, W.M., Moorat, A., Gardner, S., Woessner, M., Bourne, E., Brosgart, C.L., Schiff, E.: Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology 2004; 126: 81–90

    CrossRef  CAS  PubMed  Google Scholar 

  41. Peters, M.G., Hann, H.W., Martin, P., Heathcote, E.J., Buggisch, P., Rubin, R., Bourliere, M., Kowdley, K., Trepo, C., Gray, D.F., Sullivan, M., Kleber, K., Ebrahimi, R., Xiong, S., Brosgart, C.L.: Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 2004; 126: 91–101

    CAS  PubMed  Google Scholar 

  42. Qaqish, R.B., Mattes, K.A., Ritchie, D.J.: Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection. Clin. Ther. 2003; 25: 3084–3099

    CrossRef  CAS  PubMed  Google Scholar 

  43. Roche, B., Samuel, D., Gigou, M., Feray, C., Virot, V., Majno, P., Serraf, L., David, M.F., Dusseaix, E., Reynes, M., Bismuth, H.: Long-term ganciclovir therapy for hepatitis B virus infection after transplantation. J. Hepatol. 1999; 31: 584–592

    CrossRef  CAS  PubMed  Google Scholar 

  44. Schalm, S.W., Heathcote, J., Cianciara, J., Farrell, G., Sherman, M., Willems, B., Dhillon, A., Moorat, A., Barber, J., Gray, D.F.: Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomized trial. Gut 2000; 46: 562–568

    CrossRef  CAS  PubMed  Google Scholar 

  45. Schiff, E.R., Dienstag, J.L., Karayalcin, S., Grimm, I.S., Perrillo, R.P., Husa, P., de Man, R.A., Goodman, Z., Condreay, L.D., Crowther, L.M., Woessner, M.A., McPhillips, P.J., Brown, N.A.: Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. J. Hepatol. 2003; 38: 818–826

    CAS  PubMed  Google Scholar 

  46. Shaw, T., Mok, S.S., Locarnini, S.A.: Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Hepatology 1996; 24: 996–1002

    CAS  PubMed  Google Scholar 

  47. Shen, H., Alsatie, M., Eckert, G., Chalasani, N., Lumeng, L., Kwo, P.Y.: Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection. Clin. Gastroenterol. Hepatol. 2004; 2: 330–336

    CAS  PubMed  Google Scholar 

  48. Sponseller, C.A., Bacon, B.R., di Bisceglie, A.M.: Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Liver Transplant. 2000; 6: 715–720

    CrossRef  CAS  Google Scholar 

  49. Suzuki, Y., Arase, Y., Ikeda, K., Saitoh, S., Tsubota, T., Miyakawa, Y., Kumada, H.: Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop. Intervirology 2003; 46: 164–170

    CAS  PubMed  Google Scholar 

  50. Tamam, L., Yerdelen, D., Ozpoyraz, N.: Psychosis associated with interferon alfa therapy for chronic hepatitis B. Ann. Pharmacother. 2003; 37: 384–387

    CrossRef  PubMed  Google Scholar 

  51. Trépo, C., Jezek, P., Atkinson, G., Boon, R., Young, C.: Famciclovir in chronic hepatitis B: results of a dose-finding study. J. Hepatol. 2000; 32: 1011–1018

    PubMed  Google Scholar 

  52. Vajro, P., Migliaro, F., Fontanella, A., Orso, G.: Interferon: a metaanalysis of published studies in chronic hepatitis B. Acta Gastroenterol. Belg. 1998; 61: 219–223

    CAS  PubMed  Google Scholar 

  53. Villeneuve, J.-P., Condreay, L.D., Willems, B., Pomier-Layrargues, G., Fenyves, D., Bilodeau, M., Leduc, R., Peltekian, K., Wong, F., Margulies, M., Heathcote, E.J.: Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000; 31: 207–210

    CrossRef  CAS  PubMed  Google Scholar 

  54. Werle, B., Cinquin, K., Marcellin, P., Pol, S., Maynard, M., Trepo, C., Zoulim, F.: Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy. J. Viral Hepat. 2003; 11: 74–83

    Google Scholar 

  55. Westland, C.E., Yang, H.L., Delaney, W.E., Gibbs, C.S., Miller, M.D., Wulfsohn, M., Fry, J., Brosgart, C.L., Xiong, S.: Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B. Hepatology 2003; 38: 96–103

    CAS  PubMed  Google Scholar 

  56. Yokosuka, O.: Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis (editorial). J. Gastroenterol. 2004; 39: 813–814

    CrossRef  PubMed  Google Scholar 

Therapy of chronic hepatitis C

  1. Adinolfi, L.E., Utili, R., Tonziello, A., Ruggiero, G.: Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon nonresponsive chronic hepatitis C: a randomized trial. Gut 2003; 52: 701–705

    CrossRef  CAS  PubMed  Google Scholar 

  2. Arase, Y., Ikeda, K., Tsubota, A., Suzuki, Y., Saitoh, S., Kobayashi, M., Suzuki, F., Akuta, N., Someya, T., Hosaka, T., Kobayashi, M., Kumada, H.: Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy. J. Gastroenterol. 2004; 39: 455–460

    CAS  PubMed  Google Scholar 

  3. Bajaj, J.S., Molina, E., Regev, A., Schiff, E.R., Jeffers, L.J.: Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2b and ribavirin in chronic hepatitis C. Gastrointest. Endosc. 2003; 58: 380–383

    CrossRef  PubMed  Google Scholar 

  4. Berg, T., Kronenberger, B., Hinrichsen, H., Gerlach, T., Buggisch, P., Herrmann, E., Spengler, U., Goeser, T., Nasser, S., Wursthorn, K., Pape, G.R., Hopf, U., Zeuzem, S.: Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. Hepatology 2003; 37: 1359–1367

    CAS  PubMed  Google Scholar 

  5. Buti, M., Medina, M., Casado, M.A., Wong, J.B., Fosbrook, L., Esteban, R.: A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C. Alim. Pharm. Ther. 2003; 17: 687–694

    CAS  Google Scholar 

  6. Calleja, J.L., Albillos, A., Moreno-Otero, R., Rossi, I., Cacho, G., Domper, F., Yebra, M., Escartin, P.: Sustained response to interferon-α or to interferon-α plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment. Pharmacol. Ther. 1999; 13: 1179–1186

    CrossRef  CAS  PubMed  Google Scholar 

  7. Camma, C., Di Bona, D., Schepis, F., Heathcote, E.J., Zeuzem, S., Pockross, P.J., Marcellin, P., Balart, L., Alberti, A., Craxi, A.: Effect of peginterferon α-2a on liver histology in chronic hepatitis C: a metaanalysis of individual patient data. Hepatology 2004; 39: 333–342

    CAS  PubMed  Google Scholar 

  8. Chaudhari, S., Park, J., Anand, B.S., Pimstone, N.R., Dieterich, D.T., Batash, S., Bini, E.J.: Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 2004; 49: 1000–1006

    CrossRef  CAS  PubMed  Google Scholar 

  9. Cheng, P.N., Chow, N.H., Hu, S.C., Young, K.C., Chen, C.Y., Jen, C.M., Chang, T.T.: Clinical comparison of high-dose interferon-alpha 2b with or without ribavirin for treatment of interferon-relapsed chronic hepatitis C. Dig. Dis. Sci. 2002; 34: 851–856

    CAS  Google Scholar 

  10. Di Bisceglie, A.M., Bonkovsky, H.L., Chopra, S., Flamm, S., Reddy, R.K., Grace, N., Killenberg, P., Hunt, C., Tamburro, C., Tavill, A.S., Ferguson, R., Krawitt, E., Banner, B., Bacon, B.R.: Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology 2000; 32: 135–138

    PubMed  Google Scholar 

  11. Di Marco, V., Almasio, P., Vaccaro, A., Ferraro, D., Parisi, P., Cataldo, M.G., di Stefano, R., Craxi, A.: Combined treatment of relapse of chronic hepatitis C with high-dose alpha (2) b interferon plus ribavirin for 6 or 12 months. J. Hepatol. 2000; 33: 456–462

    CrossRef  CAS  PubMed  Google Scholar 

  12. Duchatelle, V., Marcellin, P., Giostra, E., Bregeaud, L., Pouteau, M., Boyer, N., Auperin, A., Guerret, S., Erlinger, S., Henin, D., Degott, C.: Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. J. Hepatol. 1998; 29: 20–28

    CrossRef  CAS  PubMed  Google Scholar 

  13. Gitlin, N.: Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur. J. Gastroenterol. Hepatol. 2002; 14: 883–885

    CrossRef  PubMed  Google Scholar 

  14. Hadziyannis, S.J., Settl, H., Morgan, T.R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., Zeuzem, S., Pockros, P.J., Lin, A., Ackrill, A.M.: Peginterferon-alpha 2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 2004; 140: 346–356

    CAS  PubMed  Google Scholar 

  15. Hasan, F., Asker, H., Al-Khaldi, J., Siddique, I., Al-Ajmi, M., Owaid, S., Varghese, R., Al-Nakib, B.: Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Amer. J. Gastroenterol. 2004; 99: 1733–1737

    CAS  Google Scholar 

  16. Inoue, K., Sekiyama, K., Yamada, M., Watanabe, T., Yasuda, H., Yoshiba, M.: Combined interferon alpha 2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. Gastroenterol. 2003; 38: 567–572

    CAS  Google Scholar 

  17. Itoh, Y., Okanoue, T.: Ribavirin-induced hemolytic anemia in chronic hepatitis C patients (editorial). J. Gastroenterol. 2004; 39: 704–705

    CrossRef  PubMed  Google Scholar 

  18. Jacobson, I.M., Ahmed, F., Russo, M.W., Lebovics, E., Dieterich, D.I., Esposito, S.P., Bach, N., Klion, F., Tobias, H., Antignano, L., Brown, R.S., Gabbaizadeh, D., Geders, J., Levendoglu, H.: Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT. Amer. J. Gastroenterol. 2004; 99: 1700–1705

    CAS  Google Scholar 

  19. Kumar, K.S., Russo, M.W., Borczuk, A.C., Brown, M., Esposito, S.P., Lobritto, S.J., Jacobson, I.M., Brown, R.S.: Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Amer. J. Gastroenterol. 2002; 97: 2432–2440

    CAS  Google Scholar 

  20. Myers, R.P., Thibault, V., Poynard, T.: The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C. J. Viral Hepat. 2003; 10: 103–110

    CAS  PubMed  Google Scholar 

  21. Nakagawa, M., Sakamoto, N., Enomoto, N., Tanabe, Y., Kanazawa, N., Koyama, T., Kurosaki, M., Maekawa, S., Yamashiro, T., Chen, C.H., Itsui, Y., Kakinuma, S., Watanabe, M.: Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem. Biophys. Res. Com. 2004; 313: 42–47

    CAS  PubMed  Google Scholar 

  22. Pockros, P.J., Carithers, R., Desmond, P., Dhumeaux, D., Fried, M.W., Marcellin, P., Shiffman, M.L., Minuk, G., Reddy, K.R., Reindollar, R.W., Lin, A., Brunda, M.J.: Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon controlled trial. Amer. J. Gastroenterol. 2004; 99: 1298–1305

    CAS  Google Scholar 

  23. Poupon, R.E., Bonnand, A.M., Queneau, P.E., Trépo, C., Zarski, J.P., Vetter, D., Raabe, J.J., Thieffin, G., Larrey, D., Grange, J.D., Capron, J.P., Serfaty, L., Chrétien, Y., St.-Girardin, M.F., Mathiex-Fortunet, H., Zafrani, E.S., Guéchot, J., Beuers, U., Paumgartner, G., Poupon, R.: Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon. Scand. J. Gastroenterol. 2000; 35: 642–649

    CrossRef  CAS  PubMed  Google Scholar 

  24. Poynard, T., Ratziu, V., McHutchison, J., Manns, M., Goodman, Z., Zeuzem, S., Younossi, Z., Albrecht, J.: Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003; 38: 75–85

    CAS  PubMed  Google Scholar 

  25. Reddy, K.R., Wright, T.L., Pockros, P.J., Shiffman, M., Everson, G., Reindollar, R., Fried, M.W., Purdum, P.P., Jensen, D., Smith, C., Lee, W.M., Boyer, T.D., Lin, A., Pedder, S., DePamphilis, J.: Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology 2001; 33: 433–438

    CrossRef  CAS  PubMed  Google Scholar 

  26. Russo, M.W., Fried, M.W.: Side-effect of therapy for chronic hepatitis C. Gastroenterology 2003; 124: 1711–1719

    CrossRef  PubMed  Google Scholar 

  27. Saracco, G., Ciancio, A., Ghisetti, V., Rocca, G., Cariti, G., Andreoni, M., Tabone, M., Roffi, L., Calleri, G., Ballaré, M., Terreni, N., Sartori, M., Tappero, G.F., Travero, A., Poggio, A., Orani, A., Maggi, G., di Napoli, A., Arrigoni, A., Rizetto, M.: Treatment with interferon-alpha 2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. Eur. J. Gastroenterol. Hepatol. 2001; 13: 149–155

    CrossRef  CAS  PubMed  Google Scholar 

  28. Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R., Martin, G., Schindlbeck, N., Heldwein, W., Soyka, M., Grunze, H., Koenig, A., Loeschke, K.: Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003; 37: 443–451

    CrossRef  CAS  PubMed  Google Scholar 

  29. Sherman, K.E., Sjogren, M., Creager, R.L., Damiano, M.A., Freeman, St., Lewey, S., Davis, D., Root, S., Weber, F.L., Ishak, K.G., Goodman, Z.D.: Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Hepatology 1998; 27: 1128–1135

    CrossRef  CAS  PubMed  Google Scholar 

  30. Shiffman, M.L., Hoffmann, C.M., Gabbay, J., Luketic, V.A., Sterling, R.K., Sanyal, A.J., Contos, M.J., Ryan, M.J., Yoshida, C., Rustgi, V.: Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. Amer. J. Gastroenterol. 2000; 95: 2928–2935

    CAS  Google Scholar 

  31. Smith, J.P.: Treatment of chronic hepatitis C with amantadine. Dig. Dis. Sci. 1997; 42: 1681–1687

    CrossRef  CAS  PubMed  Google Scholar 

  32. Smith, J.P., Riley, T.R., Bingaman, S., Mauger, D.T.: Amantadine therapy for chronic hepatitis C: a dose escalation study. Amer. J. Gastroenterol. 2004; 99: 1099–1104

    CAS  Google Scholar 

  33. Tahan, V., Ozseker, F., Guneylioglu, D., Baran, A., Ozaras, R., Mert, A., Ucisik, A.C., Cagatay, T., Yilmazbayhan, D., Senturk, H.: Sarcoidosis after use of interferon for chronic hepatitis C-Report of a case and review of the literature. Dig. Dis. Sci. 2003; 48: 169–173

    CrossRef  CAS  PubMed  Google Scholar 

  34. Takimoto, M., Ohkoshi, S., Ichida, T., Takeda, Y., Nomoto, M., Asakura, A., Naito, A., Mori, S., Hata, K., Igarashi, K., Hara, H., Ohta, H., Soga, K., Watanabe, T., Kamimura, T.: Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C. A retrospective multicenter analysis of 652 patients. Dig. Dis. Sci. 2002; 47: 170–176

    CrossRef  CAS  PubMed  Google Scholar 

  35. Tanaka, H., Tsukuma, H., Kasahara, A., Hayashi, N., Yoshihara, H., Masuzawa, M., Kanda, T., Kashiwagi, T., Inoue, A., Kato, M., Oshima, A., Kinoshita, Y., Kamada, T.: Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. Int. J. Cancer 2000; 87: 741–749

    CrossRef  CAS  PubMed  Google Scholar 

  36. Tanaka, N., Kiyosawa, K.: Phlebotomy: a promising treatment for chronic hepatitis C (editorial). J. Gastroenterol. 2004; 39: 601–603

    PubMed  Google Scholar 

  37. Thuluvath, P.J., Pande, H., Maygers, J.: Combination therapy with interferon-alpha (2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin. Dig. Dis. Sci. 2003; 48: 594–597

    CAS  PubMed  Google Scholar 

  38. Toccaceli, F., Laghi, V., Capurso, L., Koch, M., Sereno, S., Scuderi, M.: Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon. J. Viral Hepat. 2003; 10: 126–133

    CrossRef  CAS  PubMed  Google Scholar 

  39. Ullerich, H., Avenhaus, W., Poremba, C., Domschke, W., Menzel, J.: High-dose interferon alpha-2a with ribavirin and amantadine in naive chronic hepatitis C patients-results of a randomized, prospective, pilot study. Alim. Pharm. Ther. 2002; 16: 2107–2114

    CAS  Google Scholar 

  40. Van Rossum, T.G.J., Vulto, A.G., de Man, R.A., Brouwer, J.T., Schalm, S.W.: Review article: Glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment. Pharm. Ther. 1998; 12: 199–205

    Google Scholar 

  41. Yoshida, H., Arakawa, Y., Sata, M., Nishiguchi, S., Yano, M., Fujiyama, S., Yamada, G., Yokosuka, O., Shiratori, Y., Omata, M.: Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology 2002; 123: 483–491

    CAS  PubMed  Google Scholar 

  42. Younossi, Z.M., Mullen, K.D., Hodnick, S., Barnes, D.S., Carey, W.D., McCullough, A.C., Easley, K., Gramlich, T., Liebermann, B.Y.: Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C. J. Clin. Gastroenterol. 2003; 36: 427–430

    CrossRef  CAS  PubMed  Google Scholar 

  43. Zeuzem, S., Teuber, G., Naumann, U., Berg, T., Raedle, J., Hartmann, S., Hopf, U.: Randomized, double-blind, placebo-controlled trial of interferon alfa 2a with and without amantadine as initial treatment for chronic hepatitis C. Hepatology 2000; 32: 835–841

    CrossRef  CAS  PubMed  Google Scholar 

  44. Zeuzem, S., Heathcote, E.J., Shiffman, M.L., Wright, T.L., Bain, V.G., Sherman, M., Feinman, S.V., Fried, M.W., Rasenack, J., Sarrazin, C., Jensen, D.M., Lin, A., Hoffman, J.H., Sedarati, F.: Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C. J. Hepatol. 2003; 39: 106–111

    CrossRef  CAS  PubMed  Google Scholar 

  45. Zeuzem, S., Hultcrantz, R., Bourliere, M., Goeser, T., Marcellin, P., Sanchez-Tapias, J., Sarrazin, C., Harvey, J., Brass, C., Albrecht, J.: Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J. Hepatol. 2004; 40: 993–999

    CrossRef  CAS  PubMed  Google Scholar 

  46. Zilly, M., Lingenauber, C., Desch, S., Väth, T., Klinker, H., Langmann, P.: Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin. Eur. J. Med. Res. 2002; 7: 149–154

    CAS  PubMed  Google Scholar 

  47. Zoulim, F., Zaem, J., Si Ahmed, S., Chossegros, P., Habersetzer, F., Chevallier, M., Bailly, F., Trépo, C.: Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients. J. Viral Hepatit. 1998; 5: 193–198

    CAS  Google Scholar 

Therapy of chronic hepatitis D

  1. Farci, P., Roskams, T., Chessa, L., Peddis, G., Mazzoleni, A.P., Scioscia, R., Serra, G., Lai, M.E., Loy, M., Caruso, L., Desmet, V., Purcell, R.H., Balestrieri, A.: Long-term benefit of interferon-α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 2004; 126: 1740–1749

    CrossRef  CAS  PubMed  Google Scholar 

  2. Gaudin, J.L., Faure, P., Godinot, H., Gerard, F., Trepo, C.: The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2b. Results of a randomized controlled trial. Liver 1995; 15: 45–52

    CAS  PubMed  Google Scholar 

  3. Wolters, L.M.M., van Nunen, A.B., Honkoop, P., Vossen, A.C.T.M., Niesters, H.G.M., Zondervan, P.E., de Man, R.A.: Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J. Viral Hepat. 2000; 7: 428–434

    CrossRef  CAS  PubMed  Google Scholar 

  4. Yurdaydin, C., Bozkaya, H., Gürel, S., Tillmann, H.L., Aslan, N., Okcu-Heper, A., Erden, E., Yalcin, K., Iliman, N., Uzunalimoglu, Ö., Manns, M.P., Bozdayi, A.M.: Famciclovir treatment of chronic delta hepatitis. J. Hepatol. 2002; 37: 266–271

    CrossRef  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2006). Chronic hepatitis. In: Hepatology Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28977-1_34

Download citation

  • DOI: https://doi.org/10.1007/3-540-28977-1_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28976-0

  • Online ISBN: 978-3-540-28977-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation